Skip to content
DraconiticResearch
Search Sources API
181,686 studies31 sourcesUpdated 52 min ago
PreprintarXiv licencearXiv

Efficient transport and generalization of survival treatment effects

Abstract

Randomized controlled trials provide internally valid estimates of treatment effects, but their results may not directly apply to broader target populations due to differences in baseline covariate distributions, adherence to treatment or variations in outcome mechanisms. Under standard transport and time-to-event identifiability assumptions, we develop nonparametric, debiased machine learning estimators for transporting and generalizing causal survival treatment effect differences from a source population to a target population in discrete time. We derive the efficient influence functions for the transport and generalization survival difference estimands and propose cross-fitted one-step estimators that are doubly robust and achieve semiparametric efficiency bounds under weak regularity conditions. We further introduce estimators that exploit known effect modifier subsets through an additive parameterization of the survival function, reducing the dimensionality of the reweighting and yielding smaller or equal asymptotic variance. We establish asymptotic normality, double robustness, and rates of convergence for all proposed estimators. Finite-sample properties are illustrated through Monte Carlo simulations under flexible and misspecified nuisance estimation scenarios. We apply the methods to data from the Women's Health Initiative to estimate the effect of hormone therapy on coronary heart disease across trial and observational populations.

Related

  1. Post-Progression Treatment Regimes and the Limits of Cross-Trial Survival Transport
    Federico Felizzi, Noman Paracha
    arXivPreprintCC BY 4.0Full textStatisticsarXiv
  2. Efficient Causal Survival Inference under Limited Surrogate Monitoring
    Zhenyue Du, Weishang Kong, Wei Li
    arXivPreprintarXiv licenceFull textStatisticsarXiv
  3. Max-Stable Survival Copulas under Dependent Censoring: Sharp Identification and Efficient Inference
    Djibril Gueye, Salima Helali, Modou Wade
    arXivPreprintarXiv licenceFull textStatisticsarXiv
  4. Exact Survival Recurrence beyond Rate Homogenization in Periodic Transport
    Quentin Thommen
    HALPreprintCC BY 4.0Full textMathematical physicsGeneral physicsHAL
  5. Sparse Dictionary Learning for Measure-Valued Data via Linearized Optimal Transport: Efficient Algorithms and Sample Complexity
    Brendan Mallery, Shuchin Aeron, James Murphy
    arXivPreprintCC BY 4.0Full textStatisticsarXiv
BibTeX
@misc{martin2026efficient,
  title = {{Efficient transport and generalization of survival treatment effects}},
  author = {Axel Martin and Iván Díaz and Michele Santacatterina},
  howpublished = {arXiv},
  year = {2026},
  month = sep,
  doi = {10.48550/arxiv.2609.18764},
  eprint = {2609.18764},
  archivePrefix = {arXiv},
  url = {https://arxiv.org/abs/2609.18764},
}
RIS
TY  - UNPB
TI  - Efficient transport and generalization of survival treatment effects
AU  - Axel Martin
AU  - Iván Díaz
AU  - Michele Santacatterina
PY  - 2026
DA  - 2026/09/16
PB  - arXiv
DO  - 10.48550/arxiv.2609.18764
UR  - https://arxiv.org/abs/2609.18764
AB  - Randomized controlled trials provide internally valid estimates of treatment effects, but their results may not directly apply to broader target populations due to differences in baseline covariate distributions, adherence to treatment or variations in outcome mechanisms. Under standard transport and time-to-event identifiability assumptions, we develop nonparametric, debiased machine learning estimators for transporting and generalizing causal survival treatment effect differences from a source population to a target population in discrete time. We derive the efficient influence functions for the transport and generalization survival difference estimands and propose cross-fitted one-step estimators that are doubly robust and achieve semiparametric efficiency bounds under weak regularity conditions. We further introduce estimators that exploit known effect modifier subsets through an additive parameterization of the survival function, reducing the dimensionality of the reweighting and yielding smaller or equal asymptotic variance. We establish asymptotic normality, double robustness, and rates of convergence for all proposed estimators. Finite-sample properties are illustrated through Monte Carlo simulations under flexible and misspecified nuisance estimation scenarios. We apply the methods to data from the Women's Health Initiative to estimate the effect of hormone therapy on coronary heart disease across trial and observational populations.
ER  -